Literature DB >> 27265462

Detection of emerging rotavirus G12P[8] in Sonora, México.

G González-Ochoa, G de J, P M Calleja-García, J A Rosas-Rodríguez, A Virgen-Ortíz, P Tamez-Guerra.   

Abstract

Rotavirus is the most common cause of gastroenteritis in children up to five years of age worldwide. The aim of the present study was to analyze the genotypes of rotavirus strains isolated from children with gastroenteritis, after the introduction of the rotavirus vaccine in México. Rotavirus was detected in 14/100 (14%) fecal samples from children with gastroenteritis, using a commercial test kit. The viral genome was purified from these samples and used as a template in RT-PCR amplification of the VP4 and VP7 genes, followed by gene cloning and sequencing. Among the rotavirus strains, 4/14 (28.5%) were characterized as G12P[8], 2/14 (14.3%), as G12P (not typed), and 3/14 (21.42%) as G (not typed) P[8]. Phylogenetic analysis of the VP7 gene showed that G12 genotypes clustered in lineage III. Phylogenetic analysis revealed that VP4 genotype P[8] sequences clustered in lineage V, whereas other P[8] sequences previously reported in Mexico (2005-2008) clustered in different lineages. Rotavirus genotype G12 is currently recognized as a globally emerging rotavirus. To our knowledge, this is the first report of this emerging rotavirus strain G12P[8] in México. Ongoing surveillance is recommended to monitor the distribution of rotavirus genotypes and to continually reassess the suitability of currently available rotavirus vaccines.

Entities:  

Keywords:  rotavirus; gastroenteritis; G12P[8].

Mesh:

Substances:

Year:  2016        PMID: 27265462     DOI: 10.4149/av_2016_02_136

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  1 in total

1.  Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017.

Authors:  Giovanni Ianiro; Roberto Micolano; Ilaria Di Bartolo; Gaia Scavia; Marina Monini
Journal:  Euro Surveill       Date:  2019-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.